Aug 2026· Critical reviews in biochemistry and molecular biology· pp.
1-23
· 0 citations· 209 references
Medicine
TL;DR
Therapeutically targeting G4s requires balancing their essential regulatory roles with their pathological effects, and understanding this tension is essential for exploiting G4s as therapeutic targets across cancer types.
Abstract
G-quadruplexes (G4s) are essential regulatory structures whose biological functions are inseparable from their potential to destabilize the genome. They play critical roles in transcription, replication and chromatin architecture, yet they also contribute to the genomic instability that fuels cancer. This dual role is an inherent consequence of where G4s form in the genome. G4s are enriched at highly active regulatory regions, including promoters, replication origins and topologically associated domain boundaries, where their controlled formation and resolution by helicases and topoisomerases support normal genome function. When this control is lost, the same features that make G4s functional become harmful, leading to R-loop and G-loop accumulation, replication fork stalling and increased conflicts between transcription and replication. Topoisomerase activity, which normally relieves supercoiling stress, can instead generate the DNA double-strand breaks that characterize cancer genomes. Persistent G4 structures also promote micronuclei formation and cytoplasmic DNA accumulation, activating the cGAS-STING innate immune signaling pathway. Here, we discuss these mechanisms and present pan-cancer genomic analyses showing that these processes operate broadly across human tumors. Therapeutically targeting G4s requires balancing their essential regulatory roles with their pathological effects. Understanding this tension is therefore essential for exploiting G4s as therapeutic targets across cancer types.
It is suggested that R-loops function as double-edged swords necessary for accurate chromosome segregation under physiological conditions, yet are deleterious if not resolved and improperly regulated.
Prashant K. Mishra, M. Basrai· Open Biology· 0 citations
A unified view is provided of how genome structure is established, how it relates to function, and how its disruption contributes to tumorigenesis, suggesting that alterations in genome structure can, in some contexts, actively reshape oncogenic programs.
Rebecca G. Smith, Hannah M. Wilson, Kathleen L. Schiela et al.· Genes & Development· 0 citations
Hepatitis B virus (HBV) infection poses a global threat to human health due to the limited availability of effective treatment options. Recent studies have shown that the structures of G-quadruplex (G4) are related to the pathogenesis of the virus and potential targets for antiviral therapy. G-quadruplex-binding protei...
Li-Na He, Bao-Yue Huang, Hai-Yang Ma et al.· Virology Journal· 0 citations
The results indicate that G-quadruplex-prone sequences represent a common genomic feature associated with a number of human transcription factors and chromatin-associated regulatory proteins and support a model in which G4-rich regions act as selective regulatory scaffolds shaping transcription factor occupancy and gen...
Karolína Drápalová, Michaela Dobrovolná, Filip Kledus et al.· BMC Genomics· 0 citations
It is shown that ecDNAs, in contrast to chromosomal DNA, preferentially localize to the nuclear periphery yet resist peripheral gene silencing, and single-molecule multi-omic sequencing and imaging-based CRISPR screening demonstrate enhanced ecDNA hub formation, H3K27ac and H3K9me3 bivalency, late DNA replication, long...
Yan-Bo Wang, Xiao-Wei Yan, Natasha E. Weiser et al.· bioRxiv· 0 citations
Findings show that ecDNA is more than a carrier of amplified genes and its presence is associated with altered DNA-damage responses and specific cellular dependencies, supporting the idea that ecDNA itself imposes biological constraints on cancer cells and creates vulnerabilities that may be therapeutically exploitable...
M. Ilić· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.